T/FIF, a New Plateau Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (421)	4/11/2001 2:56:48 PM
From: Mark Bong	of 2243

Tuck, Angiomax, which was licensed from BGEN was approved and looks good. They will expand market indications, but the overall market is not that large, and there seems to be a lot of competition. I have looked at Medicines Co before, and I do not find it a compelling valuation. I feel that there are many others out there, many that you have mentioned that offer better value. Take care. Mark

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next